Funding Rounds
Asgard Therapeutics Seed (2021, $6M)
Asgard TherapeuticsDeveloper of vivo direct cell reprogramming for cancer immunotherapy.
Summary
Stage: Seed
Raised Amount: $6.87M
Raised Date: 2021-01-01
Stage: Seed
Raised Amount: $6.87M
Raised Date: 2021-01-01